News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
24-Sep-2008 - Acacia Pharma has initiated its first clinical trial, a Phase I study of its lead product candidate APD 405. APD 405 is being developed for the prevention and treatment of nausea & vomiting, which remains a common problem after surgery and after treatment with many cancer chemotherapy drugs. The ...
US$10 million received based on the positive review of interim analysis for international pivotal multiple sclerosis trial
24-Sep-2008 - BioMS Medical Corp. announced that it has received the US$10 million milestone payment from its partner, Eli Lilly and Company. The milestone payment is based on the previously announced positive review of the scheduled interim analysis of the Company's pivotal phase II/III Canadian and ...
23-Sep-2008 - Aesica announced it has taken a key step in further expanding its international presence with the establishment of a US subsidiary, Aesica LLC, which is based in Saddle Brook, New Jersey. The subsidiary will be headed by Michael Staff, Vice President, Sales & Business Development, North America ...
QIAGEN's careHPV test provides "substantially more accurate"
23-Sep-2008 - A new HPV (human papillomavirus) test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries. The first ...
23-Sep-2008 - BioAlliance Pharma SA announced that Madame Dominique Costantini, President of the company's Executive Board, had been awarded the Knight of the Legion of Honor insignia by Professor Claude Griscelli, a former Director of France's INSERM national institute of health and a member of the country's ...
23-Sep-2008 - VTT Technical Research Centre of Finland will coordinate the EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner. The methods ...
22-Sep-2008 - SYGNIS Pharma AG announced that it has received a positive recommendation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) for AX200 in the treatment of spinal cord injury. A spinal cord injury (SCI) is damage or trauma to the spinal cord which ...
22-Sep-2008 - Amsterdam Molecular Therapeutics announced that it obtained a license from Amgen to use their GDNF gene for the development of a gene therapy treatment for Parkinson’s disease. The combination of this gene with AMT’s proprietary adeno-associated virus (AAV) gene therapy platform could potentially ...
New COO brings financing and product development experience in the US
22-Sep-2008 - ProFibrix B.V., a Dutch biotech company focused on products to stop bleeding and initiate tissue repair, announced that it has added Jan Ohrstrom, MD as COO to its Executive Management team. Dr. Ohrstrom was previously part of the Senior Management team that took ZymoGenetics Inc public, and ...
19-Sep-2008 - Biovail Corporation announced it has acquired Prestwick Pharmaceuticals, Inc., a privately held, U.S.-based pharmaceutical company that holds the Canadian and U.S. licensing rights to Xenazine® (tetrabenazine tablets). Xenazine® was recently approved by the United States Food and Drug ...
© 1997-2024 LUMITOS AG, All rights reserved